MOST ACCESSED ARTICLE – Phytochemicals, Medicinal and Food Applications of Shatavari (Asparagus racemosus) – The Natural Products Journal

Journal:  The Natural Products Journal

Author(s): Akshay K. Singh*, Anjali Srivastava, Vivek Kumar, Karunakar Singh

Graphical Abstract:


Background: Shatavari (Asparagus racemosus), belongs to the family Asparagaceae, has got a very important place in the Ayurveda system of medicine due to its versatility in preventing and curing hundreds of different diseases. The presence of many bioactive compounds such as steroidal glycosides, saponins (mainly Shatavarins I, II, III and IV), polyphenols, flavonoids, alkaloids (racemosol) and vitamins makes it popular among all the medicinal plants. Different extracts of roots, leaves, flowers and stems of Shatavari plants are beneficial in healing the female reproductive system problems and curing a number of diseases like dyspepsia, nervous disorders, cough bronchitis, throat infections, tuberculosis etc. Several Shatavari extracts based drugs are available commercially.

Conclusion: This review includes the detailed view of phytochemistry and medicinal properties of Shatavari extracts and their application in some widely consumed food products like milk and milk products, bread, biscuits etc., which could be a good choice for the delivery of functionality of Shatavari extract to the consumers.

Read more here:


Recently Published Issue of the Journal Recent Patents on CNS Drug Discovery

Recent Patents on CNS Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to CNS Drug Discovery.

Following are the articles from the journal Recent Patents on CNS Drug Discovery, Volume 9 – Issue 2

Article: Patents on Potential Drugs to Treat Alzheimer’s Disease: Special Emphasis on Small Peptides

Author(s): Martina Iannaccone, Federica Titta, Enrica Serretiello, Marco Monfregola and Vittorio Gentile

Affiliation: Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, via Costantinopoli 16, 80138 Naples, Italy.

Article: Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors

Author(s): Carlo Matera and Ada M. Tata

Affiliation: Dept. of Biology and Biotechnologies Charles Darwin, Research Center of Neurobiology Daniel Bovet, Sapienza, University of Rome, P.le A. Moro, 5 – 00185 Roma, Italy.

Article: Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases.

Author(s): Federica Titta, Martina Iannaccone, Antonio Martin and Vittorio Gentile

Affiliation: Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, via Costantinopoli 16, 80138 Naples, Italy.

Article: Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents

Author(s): Kimberley Mander, Elizabeth Harford-Wright, Kate M. Lewis and Robert Vink

Affiliation: Division of Health Sciences, University of South Australia, South Australia, 5001, Australia

Article: Recent Patents on Novel MCH1 Receptor Antagonists as Potential Anti-Obesity Drugs

Author(s): Katalin K. Szalai, Gyula Beke, Janos Eles, Tamas Kitka, Peter Kovacs, Jozsef Nagy, Sandor Farkas and Andras Boros

Affiliation: Gyomroi u. 24, 1103 Budapest, Hungary.

For details, please visit:

%d bloggers like this: